HMGCS2 and Hepatic fibrosis: It has been reported that the inhibition of HMGCS2 in the liver will cause the impairment of hepatic ketogenesis, which can promote liver fibrosis through the various factors derived from the injured hepatocytes and activation of macrophages (Puchalska et al, 2019; Mooli & Ramakrishnan, 2022).